Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand.

ABSTRACT:

Background

Inflammatory bowel diseases (IBDs) require continuous clinical management; poor medication adherence may result in worse disease outcomes and increased healthcare costs. This study investigated medication adherence and associated risk factors in IBD patients.

Methods

Otago (New Zealand) IBD patients were mailed questionnaires on demographics, medication-taking behavior, and a validated Probabilistic Medication Adherence Scale (ProMAS).

Results

The response rate was 29.7% (n = 174/590). The study sample was mean (SD) 50.5 (16.9) years old, 57.9% female, 49.4% had Crohn's disease, and 43.9% ulcerative colitis, with median of 9.5 years (interquartile range: 5.0-22.0) of IBD duration. About 31.1% scored below medium adherence according to ProMAS. About 1

SUBMITTER: Aluzaite K 

PROVIDER: S-EPMC9802163 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature